Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

3.750 USD +0.080 (+2.18%)
Official Closing Price Updated: 5:30 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 88,800
Open 3.750
Bid (Size) 3.550 (1)
Ask (Size) 4.120 (5)
Prev. Close 3.670
Today's Range 3.570 - 3.790
52wk Range 2.960 - 6.440
Shares Outstanding 11,100,453
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Galmed Hosting KOL Symposium and Pipeline Update
Aramchol Phase 3 Trial for Non-Alcoholic Steatohepatitis and Liver Fibrosis 
From PR Newswire
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021
New Phase 1 Data Confirm Aramchol Meglumine PK Parameters Similar to Aramchol Acid 
From PR Newswire

Performance

YTD
+17.55%
+17.55%
1 Month
+4.17%
+4.17%
3 Month
+16.82%
+16.82%
6 Month
-17.04%
-17.04%
1 Year
-35.01%
-35.01%

More News

Read More
Galmed Pharmaceuticals Reports Third Quarter 2020 Financial Results
From PR Newswire
Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
From PR Newswire
Galmed Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on Thursday November 12
From PR Newswire
Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
From PR Newswire
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
From PR Newswire
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
From PR Newswire
Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
From PR Newswire
Galmed Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on Thursday August 6
From PR Newswire
Week in Review: Baidu Raising $2 Billion for New China Biopharma
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.